RenovoRx, Inc.
RNXT
$0.972
-$0.018-1.82%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.81M | -9.16M | -8.11M | -8.05M | -10.23M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -591.00K | 423.00K | -879.00K | -1.93M | -631.00K |
| Change in Net Operating Assets | 280.00K | -8.00K | -290.00K | 226.00K | 605.00K |
| Cash from Operations | -9.13M | -8.75M | -9.28M | -9.76M | -10.26M |
| Capital Expenditure | -12.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | 2.03M |
| Cash from Investing | -12.00K | 0.00 | 0.00 | 0.00 | 2.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.12M | 15.09M | 15.07M | 10.42M | 5.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.12M | 15.09M | 15.07M | 10.42M | 5.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.98M | 6.34M | 5.79M | 666.00K | -3.22M |